Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France, is providing advanced radiation treatments to cancer patients using the smart Radixact Treatment Delivery System, the first to be installed in France. The IUCT Oncopole began treating patients in January with this new system, designed to deliver image-guided intensity-modulated radiation therapy (IG-IMRT), an extremely precise form of radiation therapy.

June 20, 2017 — Breast-conserving surgery (BCS) is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries.

The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer patients advanced radiation therapy with the ViewRay MRIdian Linac system. The system uses a U.S. Food and Drug Administration (FDA)-approved real-time magnetic resonance imaging (MRI) and linear accelerator delivery for more precise and accurate radiation treatment.

The tenth special edition Image Wisely Radiation Safety Case is now available to help radiologists, imaging technologists and medical physicists assess their understanding of important radiation safety concepts, including dose monitoring and management.

Fujifilm Medical Systems U.S.A. Inc. presented its comprehensive Synapse Enterprise Imaging portfolio at the 2017 Annual Meeting of the Society for Imaging Informatics in Medicine (SIIM), held June 1-3 in Pittsburgh. The annual meeting featured advancements in medical imaging, cutting-edge scientific research and enterprise imaging thought leaders.

June 16, 2017 — The U.S. Food and Drug Administration (FDA) has expanded the indication for GE Healthcare’s imaging agent Visipaque (iodixanol) Injection. Visipaque 320 mg iodine/mL is an iso-osmolar agent that is now approved for use in coronary computed tomography angiography (CCTA) to assist in the diagnostic evaluation of adult and pediatric patients 12 years of age or older with suspected coronary artery disease in the United States.

The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Vida 3 Tesla (3T) magnetic resonance imaging (MRI) scanner from Siemens Healthineers, which features new BioMatrix technology that addresses inherent anatomical and physiological differences among patients, as well as user variability.

RamSoft announced its distribution partnership with KenQuest Medical. With RamSoft’s PowerServer and Gateway solutions, KenQuest Medical will offer clinics a software solution that can be customized to fit their workflow, enhance patient care, and ensure minimal downtime to fulfill their image management, storage, and distribution needs from a trusted source at competitive prices. 

Researchers from the University of Luxembourg, in cooperation with the University of Strasbourg, have developed a computational method that could be used to guide surgeons during brain surgery.

During the first quarter of 2017, Black Book surveyed 140 chief information officers (CIOs), 159 chief financial officers (CFOs) and 448 hospital managers involved in planning and executing population health initiatives within the next 12 months. Ninety percent of the collective respondents revealed that future population health management (PHM) systems will essentially be projected to perform as next-generation patient accounting systems.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now